Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials (Q38239192)
Jump to navigation
Jump to search
scientific article published on 12 August 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials |
scientific article published on 12 August 2014 |
Statements
1 reference
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials (English)
1 reference
M J Sorich
1 reference
M D Wiese
1 reference
A Rowland
1 reference
G Kichenadasse
1 reference
R A McKinnon
1 reference
C S Karapetis
1 reference
12 August 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference